Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HCP1302 in Patients with Erectile Dysfunction and Hypertension
NCT02587988Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Sep 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tadalafil, amlodipine in erectile dysfunction (ED), hypertension (HTN), sponsored by Hanmi Pharmaceutical. Started Sep 2014; status: completed.
02
Drugs
tadalafilamlodipine
03
Conditions
erectile dysfunction (ED)hypertension (HTN)
Beyond the preview
Go deeper on NCT02587988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587988.